| Mepha Pharma AG - Lamotrin-Mepha 50 mg, Tabletten | | 57137 | | 03 | | Lamotrin-Mepha 50 mg | | Tabletten | | N03AX09 | | Lamotrigine | | 14.07.2005 | | |
| | Composition | | lamotriginum 50 mg, calcii carbonas, sorbitolum 5.835 mg, cellulosum microcristallinum silicificatum, crospovidonum, maydis amylum, talcum, aromatica, saccharinum natricum corresp. natrium 0.412 mg, natrii stearylis fumaras, silica colloidalis anhydrica pro compresso. | | Packungsbestandteile | | Tablets | | | | | Active Agent | Dose |
|---|
| Lamotrigine | 50 mg |
| | BAG: Active Agent | Dose |
|---|
| Lamotrigine | 50 mg |
| | | | Inactive agents | Dose |
|---|
| Aromatica | | | Calcium Carbonate | | | Cellulosum Microcristallinum Silicificatum | | | Crospovidonum | | | Maydis Amylum | | | Natrii Stearylis Fumaras | | | Saccharinum Natricum | | | Silica Colloidalis Anhydrica pro Compresso | | | Sorbitol | 5.835 mg | | Talcum | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 014 | 60 Tablet(s) | 16.34 | 34.05 | B | SL | No |
|
|
